OTCMKTS:PHGUF Pharming Group (PHGUF) Stock Price, News & Analysis $0.91 0.00 (0.00%) As of 05/16/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort InterestBuy This Stock About Pharming Group Stock (OTCMKTS:PHGUF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Pharming Group alerts:Sign Up Key Stats Today's Range$0.91▼$0.9150-Day Range$0.79▼$0.9152-Week Range$0.75▼$0.99VolumeN/AAverage Volume15,292 shsMarket Capitalization$612.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.Read More… Receive PHGUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. Email Address PHGUF Stock News HeadlinesPharming Group (PHGUF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth ...May 9, 2025 | uk.finance.yahoo.comPharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)April 25, 2025 | finance.yahoo.comTrump About to Funnel $100 Billion into this Company?Trump About to Funnel $100 Billion into This Company? While everyone and the media is distracted by Trump’s tariffs… President Trump could soon funnel $100 billion into this Elon Musk company (HINT: Not Tesla).May 18, 2025 | Brownstone Research (Ad)Pharming announces positive recommendation from NICE for JoenjaApril 24, 2025 | finance.yahoo.comPharming Group to report first quarter 2025 financial results on May 8April 24, 2025 | finance.yahoo.comPharming Group N.V.: Pharming receives positive recommendation from NICE for Joenja?(leniolisib) as a treatment for APDSApril 23, 2025 | finanznachrichten.dePharming Group announces the filing of its 2024 Annual Report and Form 20-FApril 3, 2025 | finance.yahoo.comPharming Group (PHAR) Receives a Buy from H.C. WainwrightMarch 21, 2025 | markets.businessinsider.comSee More Headlines PHGUF Stock Analysis - Frequently Asked Questions How have PHGUF shares performed this year? Pharming Group's stock was trading at $0.9815 at the start of the year. Since then, PHGUF stock has decreased by 7.0% and is now trading at $0.9130. View the best growth stocks for 2025 here. How were Pharming Group's earnings last quarter? Pharming Group (OTCMKTS:PHGUF) posted its quarterly earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. Pharming Group had a negative trailing twelve-month return on equity of 7.65% and a negative net margin of 6.09%. How do I buy shares of Pharming Group? Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/05/2015Today5/18/2025Next Earnings (Estimated)7/31/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:PHGUF Previous SymbolOTC:PHGUF CIKN/A Webwww.pharming.com Phone(171) 524-7400Fax31-0-71-524-7445Employees382Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,550,000.00 Net Margins-6.09% Pretax MarginN/A Return on Equity-7.65% Return on Assets-3.82% Debt Debt-to-Equity Ratio0.53 Current Ratio3.53 Quick Ratio2.76 Sales & Book Value Annual Sales$245.32 million Price / Sales2.50 Cash Flow$0.01 per share Price / Cash Flow89.78 Book Value$0.33 per share Price / Book2.77Miscellaneous Outstanding Shares671,073,000Free FloatN/AMarket Cap$612.69 million OptionableNot Optionable Beta0.87 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (OTCMKTS:PHGUF) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Two drop-dead simple ways to play the gold boomIf you take a few minutes to check out the short research briefing Mark & I have put together, I’m confident y...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.